Cargando…
Disrupting the Oncogenic Synergism between Nucleolin and Ras Results in Cell Growth Inhibition and Cell Death
BACKGROUND: The ErbB receptors, Ras proteins and nucleolin are major contributors to malignant transformation. The pleiotropic protein nucleolin can bind to both Ras protein and ErbB receptors. Previously, we have demonstrated a crosstalk between Ras, nucleolin and the ErbB1 receptor. Activated Ras...
Autores principales: | Schokoroy, Sari, Juster, Dolly, Kloog, Yoel, Pinkas-Kramarski, Ronit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782480/ https://www.ncbi.nlm.nih.gov/pubmed/24086490 http://dx.doi.org/10.1371/journal.pone.0075269 |
Ejemplares similares
-
Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma
por: Goldshmit, Yona, et al.
Publicado: (2014) -
Ras inhibition enhances autophagy, which partially protects cells from death
por: Schmukler, Eran, et al.
Publicado: (2013) -
Chloroquine synergizes with FTS to enhance cell growth inhibition and cell death
por: Schmukler, Eran, et al.
Publicado: (2013) -
Ras and autophagy in cancer development and therapy
por: Schmukler, Eran, et al.
Publicado: (2014) -
Identification of Nucleolin as New ErbB Receptors- Interacting Protein
por: Di Segni, Ayelet, et al.
Publicado: (2008)